| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10df967672d7ee964db8eef5c41eed0c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2019-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ac6109e0041a0b1d5d93769bfde0d73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cce576d9ff131ad9207bb6759f4666b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25599ee1f29e92d3621fc3abda2149fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_421742012033eb7fa795b8ea89dfb07c |
| publicationDate |
2021-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112020019116-A2 |
| titleOfInvention |
BINDING PROTEINS, NUCLEIC ACID, VECTOR, HOST CELL, PRODUCTION METHOD, BINDING PROTEIN, PHARMACEUTICAL COMPOSITION AND KIT |
| abstract |
The present invention relates to antagonist binding proteins, a nucleic acid encoding the antagonistic binding protein, a recombinant expression vector comprising the nucleic acid molecule, a host cell comprising the vector, a method for preparing the protein antagonist-binding protein, an antagonist-binding protein produced by the method, and a pharmaceutical composition comprising the antagonist-binding protein, the nucleic acid or the vector. The present invention also relates to a kit comprising the pharmaceutical composition and the use of the antagonist binding protein in the treatment of cancer and / or chronic infectious diseases. |
| priorityDate |
2018-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |